Glenmede Trust’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-700
| Closed | -$17K | – | 1514 |
|
|
2018
Q2 | $17K | Hold |
700
| – | – | ﹤0.01% | 1757 |
|
|
2018
Q1 | $16K | Hold |
700
| – | – | ﹤0.01% | 2039 |
|
|
2017
Q4 | $16K | Hold |
700
| – | – | ﹤0.01% | 2039 |
|
|
2017
Q3 | $18K | Hold |
700
| – | – | ﹤0.01% | 2004 |
|
|
2017
Q2 | $17K | Hold |
700
| – | – | ﹤0.01% | 1969 |
|
|
2017
Q1 | $17K | Hold |
700
| – | – | ﹤0.01% | 1969 |
|
|
2016
Q4 | $14K | Hold |
700
| – | – | ﹤0.01% | 2007 |
|
|
2016
Q3 | $18K | Hold |
700
| – | – | ﹤0.01% | 1960 |
|
|
2016
Q2 | $15K | Hold |
700
| – | – | ﹤0.01% | 1983 |
|
|
2016
Q1 | $15K | Buy |
+700
| New | +$15K | ﹤0.01% | 1900 |
|